Latest filing published 17 Jun 2026 for DAVITA INC., €5.4M.
Javier Rodriguez leads Davita Inc. (Chief Executive Officer, 84 filings) and serves as a Director at Gilead Sciences, Inc. (7), for 91 filings published between April 12, 2016 and June 17, 2026. The 16 sales weigh EUR 49.6 million, with a median of EUR 1,941,804. The three largest are all at Davita Inc.: EUR 7,879,273 on February 26, 2024, EUR 7,414,954 on September 16, 2024 and EUR 7,103,404 on June 16, 2026. No purchase appears; the record holds 53 grants and 14 option exercises.
The volume peaks in 2024 (20 filings), after 14 in 2021 and 2022, then drops to 3 in 2025 and 2026. Four filings fall in the last 12 months, 2 of them sales.
At Davita Inc., 9 of Rodriguez's trades fall within 30 days of a trade by Kathleen Alyce Waters, 6 of one by Michael David Staffieri and 5 of one by James O. Hearty, all in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 91 declarations